Simple jQuery Dropdowns

Browsing by Author Etienne Karita

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
21-Jul-2018Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)Dan H. Barouch; Frank L. Tomaka; Frank Wegmann; Daniel J. Stieh; Galit Alter; Merlin L. Robb; Nelson L. Michael; Lauren Peter; Joseph P. Nkolola; Erica N. Borducchi; Abishek Chandrashekar; David Jetton; Kathryn E. Stephenson; Wenjun Li; Bette Korber; Georgia D. Tomaras; David C. Montefiori; Glenda Gray; Nicole Frahm; M. Juliana McElrath; Lindsey Baden; Jennifer Johnson; Julia Hutter; Edith Swann; Etienne Karita; Hannah Kibuuka; Juliet Mpendo; Nigel Garrett; Kathy Mngadi; Kundai Chinyenze; Frances Priddy; Erica Lazarus; Fatima Laher; Sorachai Nitayapan; Punnee Pitisuttithum; Stephan Bart; Thomas Campbell; Robert Feldman; Gregg Lucksinger; Caroline Borremans; Katleen Callewaert; Raphaele Roten; Jerald Sadoff; Lorenz Scheppler; Mo Weijtens; Karin Feddes-de Boer; Daniëlle van Manen; Jessica Vreugdenhil; Roland Zahn; Ludo Lavreys; Steven Nijs; Jeroen Tolboom; Jenny Hendriks; Zelda Euler; Maria G. Pau; Hanneke Schuitemaker; Janssen Vaccines & Prevention B.V.; Centre for the AIDS Programme of Research in South Africa; International AIDS Vaccine Initiative; Makerere University; Janssen; Massachusetts Institute of Technology; Miami Research Associates; National Institute of Allergy and Infectious Diseases; Brigham and Women's Hospital; University of Witwatersrand; HJF; Walter Reed Army Institute of Research; Mahidol University; University of Colorado at Denver; Duke University; Los Alamos National Laboratory; Royal Thai Army; Fred Hutchinson Cancer Research Center; Harvard Medical School; University of Massachusetts Medical School; Optimal Research LLC; Tekton Research; Janssen Infectious Diseases; Rwanda Zambia HIV Research Group
1-Feb-2007Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USAJim Ackland; Susan Allen; Daniel Barth-Jones; Deborah Birx; Elwyn Chomba; Gavin Churchyard; Ann Duerr; Shuigao Jin; Margaret Johnston; Patricia E. Fast; Alan Fix; Mary Foulkes; Dean Follmann; Raymond Hutubessy; Siobhan Malone; Ronald Gray; Abhay Indrayan; Jonathan Levin; Bonnie J. Mathieson; Timothy D. Mastro; John McNeil; Saladin Osmanov; Punnee Pitisuttithum; Barry Peters; Etienne Karita; Michael N. Robertson; R. Ramakrishnan; Helen Rees; Wasima Rida; Yuhua Ruan; Eric Sandström; Claudia Schmidt; Peter Smith; Steven Self; Georges Thiry; Judith Wasserheit; Frances Priddy; Ibou Thior; Mitchell Warren; David Cooper; Pontiano Kaleebu; Ruth Macklin; Godfrey Tangwa; Global BioSolutions; Rollins School of Public Health; Wayne State University School of Medicine; Centers for Disease Control and Prevention; Zambia-UAB HIV Research Project; Ernest Oppenheimer Hospital; Scientific Support Unit; Chinese Center for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases; International AIDS Vaccine Initiative; Food and Drug Administration; Organisation Mondiale de la Sante; Bill and Melinda Gates Foundation; Johns Hopkins Bloomberg School of Public Health; University College of Medical Sciences; South African Medical Research Council; OAR HIV/AIDS Vaccine Coordinating Committee; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Mahidol University; Guy's and St Thomas' NHS Foundation Trust; Projet San Francisco Rwanda; Merck & Co., Inc.; National Institute of Epidemiology; University of Witwatersrand; Statistics Collaborative; Karolinska University Hospital; London School of Hygiene & Tropical Medicine; Statistical Center for HIV/AIDS Research and Prevention; IAVI; HIV Vaccine Trials Network; Emory University; Botswana Harvard AIDS Institute Partnership; AIDS Vaccine Advocacy Coalition; Kirby Institute; Uganda Virus Research Institute; Albert Einstein College of Medicine of Yeshiva University; Universite de Yaounde I
1-Jul-2009Human immunodeficiency virus type 1 elite neutralizers: Individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithmMelissa D. Simek; Wasima Rida; Frances H. Priddy; Pham Pung; Emily Carrow; Dagna S. Laufer; Jennifer K. Lehrman; Mark Boaz; Tony Tarragona-Fiol; George Miiro; Josephine Birungi; Anton Pozniak; Dale A. McPhee; Olivier Manigart; Etienne Karita; André Inwoley; Walter Jaoko; Jack DeHovitz; Linda Gail Bekker; Punnee Pitisuttithum; Robert Paris; Laura M. Walker; Pascal Poignard; Terri Wrin; Patricia E. Fast; Dennis R. Burton; Wayne C. Koff; International AIDS Vaccine Initiative; Monogram Biosciences; Scripps Research Institute; Emory University; Uganda Virus Research Institute; National Center in HIV-1 Epidemiology and Clinical Research; St Stephen's AIDS Trust; Advanced Bioadjuvants; University of Nairobi; SUNY Downstate Medical Center; University of Cape Town; Mahidol University; Armed Forces Research Institute of Medical Sciences, Thailand; Imperial College London; Sanofi Pasteur
1-Jan-2014Performance of a redesigned HIV selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participantsOksana Penezina; Neil X. Krueger; Isaac R. Rodriguez-Chavez; Michael P. Busch; John Hural; Jerome H. Kim; Robert J. O'Connell; Eric Hunter; Said Aboud; Keith Higgins; Victor Kovalenko; David Clapham; David Crane; Andrew E. Levin; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Charla Andrews; William Kilembe; Etienne Karita; Susan Allen; Patricia Munseri; Agricola Joachim; Muhammad Bakari; Fred Mhalu; Eric Aris; Charlotta Nilsson; Gunnel Biberfeld; Merlin Robb; Mary Marovich; Eric Sandstrom; Immunetics, Inc.; National Institute of Dental and Craniofacial Research; Blood Systems Research Institute; Fred Hutchinson Cancer Research Center; Walter Reed Army Institute of Research; Armed Forces Research Institute of Medical Sciences, Thailand; Emory University; Muhimbili University of Health and Allied Sciences; Global Solutions for Infectious Diseases; Thailand Ministry of Public Health; Mahidol University; Muhimbili National Hospital; Karolinska Institutet; Swedish Institute for Communicable Disease Control; HJF
1-Jan-1994Syncytium-Inducing and Non-Syncytium-Inducing Capacity of Human Immunodeficiency Virus Type 1 Subtypes other Than B: Phenotypic and Genotypic CharacteristicsFrank de Wolf; Els Hogervorst; Jaap Goudsmit; Eva Maria Fenyö; Helga Rübsamen-Waigmann; Harvey Holmes; Bernardo Galvao-Castro; Etienne Karita; Chantapong Wasi; S. D.K. Sempala; Elly Baan; Fokla Zorgdrager; Vladimir Lukashov; Saladin Osmanov; Carla Kuiken; Marion Cornelissen; University of Amsterdam; Karolinska University Hospital; Bayer AG; National Institute for Biological Standards and Control; Reference Laboratory of the Brazilian Network on HIV Isolation and Characterization; National AIDS Control Program Rwanda; Mahidol University; Uganda Virus Research Institute; Organisation Mondiale de la Sante